Hot Products



CAS : 50-35-1
Molecular Formula : C13H10N2O4
Formula Weight : 258.23
Description :
was introduced as a sedative drug in the late 1950s. In 1961, it was withdrawn due to teratogenicity and neuropathy. There is now a growing clinical interest in thalidomide, and it is introduced as an immunomodulatory agent used primarily,combined with dexamethasone, to treat multiple myeloma. The drug is a potent teratogen in zebrafish, chickens, rabbits and primates including humans: severe birth defects may result if the drug is taken during pregnancy.It is also associated with an increased risk of deep vein thrombosis especially when combined with dexamethasone, as it is for treatment of multiple myeloma

Send enquiry online

After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
Tel: +86 592 5365868
WhatsApp: +86 189 6516 2351

Please feel free to for:the product Quotation (the product price),COA (Certificate of Analysis),New Sales Promotion,New Products,And any other assistance.